What is the preferred oral antibiotic for acute bacterial sinusitis in an adult with chronic kidney disease stage 3 (estimated glomerular filtration rate 30–59 mL/min) and a documented amoxicillin allergy?

Preferred Antibiotic for Acute Bacterial Sinusitis in Adults with CKD Stage 3 and Amoxicillin Allergy

Primary Recommendation

For an adult with CKD stage 3 (eGFR 30–59 mL/min) and documented amoxicillin allergy, prescribe a respiratory fluoroquinolone—specifically levofloxacin 500 mg once daily for 10 days—as the first-line antibiotic for acute bacterial sinusitis. 1, 2, 3

---

Diagnostic Confirmation Before Prescribing

Before initiating any antibiotic, confirm the patient meets at least one of the following criteria for acute bacterial rhinosinusitis (not viral):

• Persistent symptoms ≥10 days with purulent nasal discharge plus obstruction or facial pain/pressure 1
• Severe symptoms ≥3–4 consecutive days with fever ≥39°C, purulent discharge, and facial pain 1
• "Double sickening"—initial improvement from a viral URI followed by worsening within 10 days 1

Remember that 98–99.5% of acute rhinosinusitis is viral and resolves spontaneously within 7–10 days without antibiotics. 1

---

Why Levofloxacin Is the Optimal Choice

Coverage and Efficacy

• Levofloxacin provides 90–92% predicted clinical efficacy against the three major sinusitis pathogens: Streptococcus pneumoniae (including multidrug-resistant strains), Haemophilus influenzae (including β-lactamase producers), and Moraxella catarrhalis. 1, 4

Renal Safety in CKD Stage 3

• No dose adjustment is required for levofloxacin in CKD stage 3 (eGFR 30–59 mL/min). 1 Standard dosing of 500 mg once daily is safe and maintains therapeutic drug levels in this population.

Amoxicillin Allergy Considerations

• Respiratory fluoroquinolones are the guideline-recommended first-line agents for patients with documented severe penicillin allergy, avoiding the 1–10% cross-reactivity risk associated with cephalosporins. 1, 2, 3

---

Alternative Options (If Fluoroquinolones Contraindicated)

Second-Generation or Third-Generation Cephalosporins (If Non-Severe Allergy)

If the amoxicillin allergy is non-severe (e.g., mild rash without anaphylaxis, urticaria, or angioedema), you may safely use:

• Cefuroxime-axetil 500 mg twice daily for 10 days 1, 2
• Cefpodoxime-proxetil 200 mg twice daily for 10 days 1, 3
• Cefdinir 300 mg twice daily for 10 days 1, 2

Rationale: Cross-reactivity between penicillins and second/third-generation cephalosporins is negligible in patients without anaphylactic history. 1, 2 However, cephalosporins carry a 1–10% cross-reactivity risk with true IgE-mediated penicillin allergy and should be avoided if the allergy is severe. 3

Doxycycline (Suboptimal but Acceptable)

• Doxycycline 100 mg once daily for 10 days is an acceptable alternative but offers lower predicted efficacy (77–81%) with a 20–25% bacteriologic failure rate due to limited activity against H. influenzae. 1, 2
• Consider doxycycline only if fluoroquinolones are contraindicated (e.g., tendon disorder, QT prolongation risk) and cephalosporins cannot be used. 1

---

Antibiotics to Avoid

Azithromycin and Other Macrolides

• Do NOT use azithromycin for acute bacterial sinusitis due to resistance rates exceeding 20–25% for both S. pneumoniae and H. influenzae. 1, 2, 5 The FDA label lists azithromycin for sinusitis, but current resistance patterns make it unsuitable. 5

Trimethoprim-Sulfamethoxazole (Bactrim)

• Avoid trimethoprim-sulfamethoxazole due to 50% resistance in S. pneumoniae and 27% resistance in H. influenzae. 1, 2

First-Generation Cephalosporins

• Do NOT use cephalexin or cefadroxil because they provide inadequate coverage against H. influenzae (≈50% of strains produce β-lactamase). 1

---

Dosing and Duration

• Levofloxacin 500 mg orally once daily for 10 days (or until symptom-free for 7 consecutive days, typically 10–14 days total). 1, 2
• No renal dose adjustment is needed for CKD stage 3. 1

---

Adjunctive Therapies (Add to All Patients)

These therapies improve outcomes regardless of antibiotic choice:

• Intranasal corticosteroids (mometasone, fluticasone, or budesonide) twice daily—reduce mucosal inflammation and accelerate symptom resolution; supported by strong evidence from multiple randomized controlled trials. 1
• Saline nasal irrigation 2–3 times daily—provides symptomatic relief and clears mucus. 1
• Analgesics (acetaminophen or ibuprofen)—for pain and fever control. 1

---

Monitoring and Reassessment Protocol

Early Reassessment (Day 3–5)

• If no clinical improvement (persistent purulent drainage, unchanged facial pain, or worsening), switch antibiotics immediately. 1
• If symptoms worsen at any time (new fever, increasing pain, periorbital swelling, visual changes, severe headache, altered mental status), evaluate urgently for complications (orbital cellulitis, meningitis, intracranial abscess). 1

Day 7 Reassessment

• If symptoms persist or worsen, reconfirm the diagnosis, exclude complications, and consider imaging (CT) only if complications are suspected. 1
• Refer to otolaryngology if no improvement after 7 days of appropriate therapy. 1

Expected Timeline of Recovery

• Noticeable improvement within 3–5 days of appropriate antibiotic therapy. 1
• Complete symptom resolution by 10–14 days or when symptom-free for 7 consecutive days. 1

---

Critical Pitfalls to Avoid

• Do NOT prescribe antibiotics for symptoms <10 days unless severe features (fever ≥39°C with purulent discharge for ≥3 consecutive days) are present. 1
• Do NOT use cephalosporins without confirming the type of amoxicillin allergy; a history of anaphylaxis, urticaria, or angioedema markedly increases cross-reactivity risk. 1, 3
• Ensure minimum treatment duration of 10 days to prevent relapse. 1, 2
• Counsel patients on fluoroquinolone-associated risks: tendon rupture (especially >60 years, concurrent corticosteroids, or renal disease), QT-interval prolongation, and photosensitivity. 1

---

Referral to Otolaryngology

Refer immediately if any of the following occur:

• No clinical improvement after 7 days of appropriate fluoroquinolone therapy 1
• Any worsening of symptoms at any time during treatment 1
• Signs suggestive of complications: severe headache, visual changes, periorbital swelling/erythema, proptosis, diplopia, altered mental status, cranial nerve deficits 1
• Recurrent sinusitis (≥3 episodes per year) requiring evaluation for underlying allergic rhinitis, immunodeficiency, or anatomic abnormalities 1

---

Summary Algorithm

1. Confirm diagnosis using clinical criteria (persistent ≥10 days, severe ≥3–4 days, or "double sickening"). 1
2. Classify amoxicillin allergy:
   • Severe (anaphylaxis/Type I) → Levofloxacin 500 mg daily × 10 days 1, 2, 3
   • Non-severe (rash) → Cefuroxime, cefpodoxime, or cefdinir × 10 days 1, 2, 3
3. Add adjunctive therapies (intranasal corticosteroids, saline irrigation, analgesics). 1
4. Reassess at 3–5 days; switch antibiotics if no improvement. 1
5. Reassess at 7 days; refer to ENT if symptoms persist or worsen. 1